Health-related quality of life among older adults following acute hospitalization: longitudinal analysis of a randomized controlled trial
-
Published:2024-06-17
Issue:8
Volume:33
Page:2219-2233
-
ISSN:0962-9343
-
Container-title:Quality of Life Research
-
language:en
-
Short-container-title:Qual Life Res
Author:
Robinson Eirin GuldstenORCID, Gyllensten HannaORCID, Granas Anne GerdORCID, Halvorsen Kjell H.ORCID, Garcia Beate HennieORCID
Abstract
Abstract
Purpose
To describe the longitudinal change of health-related quality of life (HRQoL) over 12 months from acute hospitalization in older adults ≥ 70 years (IMMENSE study), and associated factors, to investigate how a medication optimization intervention influenced this change.
Methods
The EQ-5D-3L was used at discharge and 1, 6 and 12 months after discharge during a randomized controlled trial including 285 participants. Multilevel logistic (EQ-5D-3L dimensions) and mixed model regression (EQ-5D-3L index scores, EQ-VAS) were used to explore the longitudinal change with/without the intervention, and associations with medications, comorbidities, and socioeconomic variables. Subgroup analyses were performed for non-long and long stayers with hospitalizations < or ≥ 14 days.
Results
EQ-5D-3L index scores significantly declined after 12 months (β −0.06 [95% confidence interval (CI:) −0.10–−0.02], p = 0.003). Non-long stayers showed significant improvement 1 month from discharge (β 0.05 [0.00–0.09], p = 0.040). The number of medications and receiving home-care services were the main factors associated with reduced HRQoL. Being home-dwelling was the main factor associated with higher HRQoL. Non-long stayers of the intervention group reported significantly higher EQ-VAS than the control group (β 4.02 [0.11–7.93], p = 0.044).
Conclusion
We observed no significant difference in the longitudinal change in HRQoL between the two IMMENSE study groups over 12 months after hospitalization. However, the non-long stayer subgroup analysis indicates that the intervention may have had a long-term effect on HRQoL in some of intervention patients. The number of medications and the ability to live and care for oneself should be taken into consideration when planning future patient care and health-care services.
Trial registration
The trial was registered in clinicaltrials.gov on 28/06/2016 before enrolment started (NCT02816086).
Funder
University of Oslo
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Mangen, M.-J.J., Bolkenbaas, M., Huijts, S. M., van Werkhoven, C. H., Bonten, M. J. M., & de Wit, G. A. (2017). Quality of life in community-dwelling Dutch elderly measured by EQ-5D-3L. Health and Quality of Life Outcomes, 15, 3. 2. Van Wilder, L., Devleesschauwer, B., Clays, E., Pype, P., Vandepitte, S., & Smedt, D. D. (2022). Polypharmacy and health-related quality of life/psychological distress among patients with chronic disease. Preventing Chronic Disease. https://doi.org/10.5888/pcd19.220062 3. Montiel-Luque, A., Núñez-Montenegro, A. J., Martín-Aurioles, E., Canca-Sánchez, J. C., Toro-Toro, M. C., González-Correa, J. A., Polipresact Research Group. (2017). Medication-related factors associated with health-related quality of life in patients older than 65 years with polypharmacy. PLoS ONE, 12, e0171320. 4. Romskaug, R., Skovlund, E., Straand, J., Molden, E., Kersten, H., Pitkala, K., Lundqvist, C., & Wyller, T. B. (2020). Effect of clinical geriatric assessments and collaborative medication reviews by geriatrician and family physician for improving health-related quality of life in home-dwelling older patients receiving polypharmacy: A cluster randomized clinical trial. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2019.5096 5. Aljeaidi, M. S., Haaksma, M. L., & Tan, E. C. K. (2022). Polypharmacy and trajectories of health-related quality of life in older adults: An Australian cohort study. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. https://doi.org/10.1007/s11136-022-03136-9
|
|